Home
About
Overview
Sharing Data
ORCID
Help
History (4)
A phase I trial to determine the safety, tolerability, and maximum tolerated dose of deforolimus in patients with advanced malignancies.
Apparent structural differences at the tetramerization region of erythroid and nonerythroid beta spectrin as discriminated by phage displayed scFvs.
Evaluation of Genetic Predisposition for MYCN-Amplified Neuroblastoma.
Germline and mosaic mutations of FLN1 in men with periventricular heterotopia.
See All 4 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Evaluation of Genetic Predisposition for MYCN-Amplified Neuroblastoma.
Evaluation of Genetic Predisposition for MYCN-Amplified Neuroblastoma. J Natl Cancer Inst. 2017 10 01; 109(10).
View in:
PubMed
subject areas
Case-Control Studies
Gene Amplification
Gene Expression Regulation, Neoplastic
Gene Frequency
Genetic Predisposition to Disease
Genome-Wide Association Study
Humans
Neuroblastoma
N-Myc Proto-Oncogene Protein
Polymorphism, Single Nucleotide
authors with profiles
Mark Applebaum
Samuel L. Volchenboum
Susan L. Cohn